N. Farman

Type

Co-author

M. Zhao

F. Jaisser

E. Bousquet

M.C. Naud

X. Xie

M. Seminel

P.R. Rothschild

C. Rivolta

A. Prunotto

A. Matet

I. Mantel

A. Ly

X. Li

G. Leroux Les Jardins

S. Lechner

L. Jonet

B. Goldenberg

E. Gelizé

A. Gaudric

A. Dirani

M. Dernigoghossian

Y. De Kozak

A. Daruich

B. Couraud

F. Chast

J. Canonica

M.L. Brandely

T. Beydoun

C. Bergin

R. Batista

A. Arboleda

Date

Source

Serveur académique Lausannois (4)

Keyword

therapy (4) Treatment (4) Therapeutics (4) Human beings (4) Patients (3) Animals (3) Use (3) Patients (3) Spironolactone (2) Rats (2) Injections (2) Eye (2) Expression (2) Aldosterone (2) Older people (2) Receptors (2) novel (2) administration (1) psychological stress (1) protein (1) organ (1) model (1) lead (1) antagonism (1) animal (1) analysis (1) epidemiology (1) enzyme (1) effect (1) dosage (1)

Documents written by N. Farman (4) | is about N. Farman (0)

Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration.

M. Zhao et al. (Jan 21, 2019)

SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDY.

E. Bousquet et al.

Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.

A. Daruich et al. (2015)

The aldosterone-mineralocorticoid receptor pathway exerts anti-inflammatory effects in endotoxin-induced uveitis.

E. Bousquet et al. (2012)